Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana

Authors: Dorcas Obiri-Yeboah, Yaw Asante Awuku, Wonderful Alofa, Alice Charwudzi, Ebenezer Aniakwa-Bonsu, Evans Obboh, Paul Nsiah

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Kidney diseases have emerged as significant cause of morbidity and mortality in HIV subject on antiretroviral therapy (ART). In Ghana, routine follow up of HIV positive clients is by estimation of serum creatinine and urea levels. Glomerular Filtration Rate (GFR) is not routinely calculated and proteinuria is not routinely checked. This study sought to investigate the kidney profiles of adult HIV/AIDS patients being managed on ART at the Cape Coast Teaching Hospital (CCTH), Ghana.

Methods

A hospital-based analytical cross sectional study with a retrospective component was conducted using systematic sampling method to recruit HIV/AIDS who visited the ART clinic. A total of 440 participants of both sexes aged 18 years and above, confirmed as HIV/AIDS positive and on ART were involved in this study. Blood and urine samples were collected from all subjects and the levels of serum creatinine and urea and proteinuria were estimated and eGFR calculated using the Modification of Diet in Renal Disease (MDRD) equations. Data analyses were performed using Stata version 13 software (Stata Corp, Texas USA).

Results

The mean age (years) of participants was 45.5 years (±11.6) with 288 (65.4%) being on Tenofovir based ART regimen. The mean eGFR was found to decrease from 112.4 ml/min/1.73 m at baseline, to 103.4 ml/min/1.73 m after 6 months on ART and to a mean of 99.4 ml/min/1.73 m at recruitment into this study. Factors which were found to be associated with having eGFR < 60 included age, gender and CD4 count though not statistically significant. Patients > 45 years had the highest odds with OR 2.0 (95% CI: 0.8–5.1), females had higher odds with OR 1.5 (95% CI: 0.5–5.2), and those with CD4 count > 350 had OR of 0.4 (95% CI 0.2–1.3). A total of 30.9% of the participants had proteinuria at recruitment. TDF based ART regimen had no statistically significant effect on serum creatinine and urea levels.

Conclusion

Estimated GFR decreased after 6 months among patients on ART despite normal serum creatinine and urea levels. This finding suggests that clients in care at HIV/ART clinics in Ghana may benefit from routine estimation of GFR and proteinuria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Palella FJ Jr, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.CrossRef Palella FJ Jr, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.CrossRef
2.
go back to reference Mpondo BCT, et al. Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study. PLoS One. 2014;9(2):e89573.CrossRef Mpondo BCT, et al. Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study. PLoS One. 2014;9(2):e89573.CrossRef
3.
go back to reference Flandre P, et al. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6(7):1700–7.CrossRef Flandre P, et al. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6(7):1700–7.CrossRef
4.
go back to reference Winston J, et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47(11):1449–57.CrossRef Winston J, et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47(11):1449–57.CrossRef
5.
go back to reference Solomon MM, et al. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. Aids. 2014;28(6):851–9.CrossRef Solomon MM, et al. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. Aids. 2014;28(6):851–9.CrossRef
6.
go back to reference Reynes J, et al. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate >/= 60 ml/min per 1.73 m2. Aids. 2013;27(8):1295–302.CrossRef Reynes J, et al. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate >/= 60 ml/min per 1.73 m2. Aids. 2013;27(8):1295–302.CrossRef
7.
go back to reference Gupta SK, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.CrossRef Gupta SK, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.CrossRef
8.
go back to reference Owiredu W, et al. Renal insufficiency in Ghanaian HIV infected patients: need for dose adjustment. Afr Health Sci. 2013;13(1):101–11.PubMedPubMedCentral Owiredu W, et al. Renal insufficiency in Ghanaian HIV infected patients: need for dose adjustment. Afr Health Sci. 2013;13(1):101–11.PubMedPubMedCentral
9.
go back to reference Guidelines for antiretroviral therapy in Ghana. Accra: Ghana Health Service/National AIDS/STI Control Programme; 2016. Guidelines for antiretroviral therapy in Ghana. Accra: Ghana Health Service/National AIDS/STI Control Programme; 2016.
10.
go back to reference Sarfo FS, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. J Infect. 2013;67(1):43–50.CrossRef Sarfo FS, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. J Infect. 2013;67(1):43–50.CrossRef
11.
go back to reference Obiri-Yeboah D, et al. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana. BMC Infect Dis. 2018;18(1):230.CrossRef Obiri-Yeboah D, et al. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana. BMC Infect Dis. 2018;18(1):230.CrossRef
12.
go back to reference Kooij KW, et al. Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus-infected middle-aged individuals compared with human immunodeficiency virus-uninfected controls. J Infect Dis. 2017;216(6):622–31.CrossRef Kooij KW, et al. Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus-infected middle-aged individuals compared with human immunodeficiency virus-uninfected controls. J Infect Dis. 2017;216(6):622–31.CrossRef
13.
go back to reference Juega-Mariño J, et al. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals. Medicine. 2017;96(37):e7421.CrossRef Juega-Mariño J, et al. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals. Medicine. 2017;96(37):e7421.CrossRef
14.
go back to reference Van Epps P, Kalayjian RC. Human immunodeficiency virus and aging in the era of effective antiretroviral therapy. Infect Dis Clin N Am. 2017;31(4):791–810.CrossRef Van Epps P, Kalayjian RC. Human immunodeficiency virus and aging in the era of effective antiretroviral therapy. Infect Dis Clin N Am. 2017;31(4):791–810.CrossRef
15.
go back to reference Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009;5(10):591–8.CrossRef Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009;5(10):591–8.CrossRef
16.
go back to reference Chazot R, et al. Diagnostic challenges of kidney diseases in HIV-infected patients. Expert Rev Anti-Infect Ther. 2017;15(10):903–15.CrossRef Chazot R, et al. Diagnostic challenges of kidney diseases in HIV-infected patients. Expert Rev Anti-Infect Ther. 2017;15(10):903–15.CrossRef
17.
go back to reference Some F, et al. Reversal of tenofovir induced nephrotoxicity: case reports of two patients. Pan Afr Med J. 2017;27:126.CrossRef Some F, et al. Reversal of tenofovir induced nephrotoxicity: case reports of two patients. Pan Afr Med J. 2017;27:126.CrossRef
18.
go back to reference Cirillo M, et al. Early identification of kidney disease by eGFR: what is the prevalence of eGFR in the population? J Am Soc Nephrol. 2008;21(Suppl 13):S102–6. Cirillo M, et al. Early identification of kidney disease by eGFR: what is the prevalence of eGFR in the population? J Am Soc Nephrol. 2008;21(Suppl 13):S102–6.
19.
go back to reference Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician. 2005;72(9):1723–32.PubMed Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician. 2005;72(9):1723–32.PubMed
20.
go back to reference Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013;24(10):1519–27.CrossRef Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013;24(10):1519–27.CrossRef
21.
go back to reference Kasembeli AN, et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in black south Africans. J Am Soc Nephrol. 2015;26(11):2882–90.CrossRef Kasembeli AN, et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in black south Africans. J Am Soc Nephrol. 2015;26(11):2882–90.CrossRef
22.
go back to reference Dummer PD, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.CrossRef Dummer PD, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.CrossRef
Metadata
Title
Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana
Authors
Dorcas Obiri-Yeboah
Yaw Asante Awuku
Wonderful Alofa
Alice Charwudzi
Ebenezer Aniakwa-Bonsu
Evans Obboh
Paul Nsiah
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1130-z

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.